Navigation Links
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Date:5/8/2009

th a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).

In the U.S., the Watson portfolio includes RAPAFLO(TM), GELNIQUE(TM), TRELSTAR(R) LA; TRELSTAR(R) Depot; Ferrlecit(R), INFeD(R) and Oxytrol(R). In addition, Watson markets the following brands under co-promotion agreements: AndroGel(R), with Solvay Pharmaceuticals, Inc., and Femring(R), with Warner Chilcott Limited. The Watson pipeline portfolio includes a number of products, including a six-month formulation of TRELSTAR(R), for the treatment of advanced prostate cancer which is currently under review by the FDA; URACYST(R), under development for cystitis; and a novel new oral contraceptive.

For press releases and other company information, visit the Watson website at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products, including RAPAFLO(TM); difficulties or delays in manufacturing; patents and other intellectual property rights held by the Company and the ability to successfully enforce such rights against third parties; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
2. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
3. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
4. USAID Provides $5M in Emergency Support as Swine Flu Spreads
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
6. Strativa Pharmaceuticals Provides Product Pipeline Update
7. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
8. VirtualScopics Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial
9. Savient Provides Update on Pegloticase BLA
10. USAID Provides Malaria Assistance to Zimbabwe
11. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that it will release its fiscal ... after the market close. The Company will host a ... a.m. (Eastern Time) to discuss the results. ... call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also ...
(Date:12/15/2009)... -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... 2009 special dividend payment of $1.67 per share to ... 1, 2009. With this payment, distributions to stockholders ... per share. In January 2010, the Company will ... the Company,s 2009 cash distributions and the allocation between ...
(Date:12/15/2009)... Pa., Dec. 15 West Pharmaceutical Services, Inc. ... Board of Directors has approved payment of the first-quarter ... will be paid on February 3, 2010 to shareholders ... About West ,, West is a global manufacturer ... stoppers and seals for vials, and closures and disposable ...
Breaking Medicine Technology:PDL BioPharma Completes December 15 Special Dividend Payment 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 1Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 1NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 3
(Date:12/15/2009)... 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in ... announced that shareholders had approved all three resolutions that the Company had proposed at the ... , , Description of ... Votes Non-, ... For ...
(Date:12/15/2009)... 15 Our Lady of Lourdes Health Care ... hospitals, has agreed to pay the United States $7.95 ... the Justice Department announced today. The two hospitals are ... N.J., and Lourdes Medical Center of Burlington County (LMC) ... in a suit brought by a whistleblower, Tony Kite, ...
(Date:12/15/2009)... 800,000 doses have lower strength than needed for protection, ... Almost 800,000 children,s doses of H1N1 swine flu vaccine ... they have lost some potency, federal health officials said ... Control and Prevention, the company,s routine testing of the ... years found that four batches had lower than required ...
(Date:12/15/2009)... Pa., Dec. 15 4R Systems, Inc., ... chain solutions which help retailers significantly increase profits ... decisions, announced today that The Vitamin Shoppe has ... ,, "4R,s store and DC inventory solutions have ... efficiency and in-stocks over the last two years," ...
(Date:12/15/2009)... BRAINTREE, Mass., Dec. 15 North American ... +3.9% in November year-over-year, according to the ... life insurance applications over the past three months ... 2009 levels of -1.6%, to flat at November,s ... recovering their interest in the benefits available from ...
Breaking Medicine News(10 mins):Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... Clinics Struggle to Bridge GapsSAN FRANCISCO, Jan. 15 ... California show that the shortage among allied health workers ... organizations. This shortage is causing a number of problems ... clinic,s ability to serve more patients."Community clinics represent the ...
... 15 As today,s aging population spends increasing ... for mood-enhancing foods will continue to experience healthy ... worldwide consulting and research firm Kline & ... industry has so far focused mainly on physical ...
... increasingly turning to home care vs. assisted livingGLEN ELLYN, ... has affected all aspects of life, and long term ... sell their homes, moving to an assisted living facility ... option of aging-in-place with retrofits is growing in popularity ...
... in spite of their universal health care system which ... the United Kingdom are less willing to undergo dementia ... Britons perceive greater societal stigma from diagnosis of the ... older adults in Indianapolis and 120 older adults in ...
... Deceptive Advertising ClaimsNEW YORK, Jan. 15 A class ... States District Court for the Northern District of California ... deceptive advertising in marketing its VitaminWater line of beverages. ... Kallas, LLC ("WDK"), Reese Richman LLP, and the Center ...
... Company announced today it has agreed to plead guilty ... billion in criminal and civil fines, penalties and damages ... the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded ... for its blockbuster atypical antipsychotic, Zyprexa. The settlement ...
Other Medicine News:Health News:Allied Health Worker Shortage Strains Community Clinics 2Health News:Allied Health Worker Shortage Strains Community Clinics 3Health News:Mood-Enhancing and Heart Health Foods Emerging as Incidence of Heart Diseases Rises 2Health News:Mood-Enhancing and Heart Health Foods Emerging as Incidence of Heart Diseases Rises 3Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:Does universal health care affect attitude toward dementia? 2Health News:Coca-Cola Sued Over Deceptive VitaminWater Claims 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: